During 2008-2009 in Israel, equine encephalosis virus (EEV) caused febrile outbreaks in horses. Phylogenetic analysis of segment 10 of the virus strains showed that they form a new cluster; analysis of segment 2 showed ≈92% sequence identity to EEV-3, the reference isolate. Thus, the source of this emerging EEV remains uncertain. E quine encephalosis is an arthropod-borne, noncontagious, febrile disease of horses. It was fi rst described >100 years ago by A. Theiler (1) under the name equine ephemeral fever. The disease is caused by Equine encephalosis virus (EEV; genus Orbivirus: subfamily Sedoreovirinae: family Reoviridae) (2, 3) , which is transmitted by Culicoides spp. biting midges (4) . Before 2008, EEV had been isolated only in South Africa, where 7 antigenically distinct serotypes, EEV-1-7, have been identifi ed and characterized (3) .
Orbiviruses encode at least 7 structural and 4 nonstructural (NS) proteins from 10 linear dsRNA genome segments (5) . The smallest genome segment, segment 10 (Seg-10), encodes NS3, which mediates the release of virus particles from infected cells, and NS3A. The second largest of the EEV genome segments, Seg-2, encodes virus protein (VP) 2, the larger of the 2 outer-capsid proteins. By analogy with bluetongue virus (BTV), the Orbivirus type species, the virus serotype is determined by the specifi city of interactions between VP2 and neutralizing antibodies generated during infection of the mammalian host. Consequently, VP2 and Seg-2 show sequence variations that correlate with serotype and, thus, can be used to determine the virus serotype (6) .
From October 2008 through January 2009, a febrile horse disease that was diagnosed as equine encephalosis was observed in dozens of stables across Israel (7) . The recent emergence of novel orbivirus strains (including BTV and epizootic hemorrhagic disease virus) in Europe, North America, Asia, and Australia (8) is of major concern to the worldwide livestock industry. Furthermore, the similarity of EEV to African horse sickness virus, one of the most devastating pathogens of equids, warranted further investigation of the outbreaks and molecular characterization of the virus. The molecular and sequence analyses reported here confi rm the existence of EEV in Israel and identify the virus and its serotype, as well as its phylogenetic roots.
The Study
During Figure 1 ).
Total RNA was extracted from the fi fth and sixth passages of all 3 samples by using the QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, CA, USA) to obtain suffi cient viral load for the subsequent analyses and replications. RNA was reverse transcribed into cDNA by using the Verso cDNA Kit (Thermo Fisher Scientifi c, Epsom, UK). PCR amplifi cation of the gene encoding NS3 (Seg-10) was performed on the 3 isolates by using GoTaq Green Master Mix (Promega, Madison, WI, USA) with the following primers: 5′- -3′. Thermal cycling conditions for the PCR were as previously described (9); the primer annealing temperature was modifi ed to 53.5°C. PCR products were purifi ed by using a cDNA purifi cation kit (ExoSAP-IT; USB, Cleveland, OH, USA), and sequencing was conducted by BigDye terminator cycle sequencing chemistry (Applied Biosystems, Foster City, CA, USA) in an ABI 3700 DNA Analyzer (Applied Biosystems) by using ABI data collection and sequence analysis software. Further analysis of the NS3 sequence was performed with Sequencer software, version 4.8 (Gene Codes Corp., Ann Arbor, MI, USA). Sequences were deposited in GenBank under accession nos. HQ441245 for H5, HQ441246 for H3, and HQ441247 for H8. The NS3 genes (Seg-10) were compared with those of different EEVs (9) and other related orbiviruses (Table 2) . Phylogenic trees were generated by using the neighbor-joining and maximum-likelihood The phylogenetic analyses of EEV Seg-10 grouped the Israeli isolates with other EEV isolates but as a distinct group with no close relation to African horse sickness virus, BTV, or epizootic hemorrhagic disease virus. Within the EEV group, 3 discrete clusters (A, B, C) were recognized; the Israeli isolates formed one of these clusters (C; Figure  2 ). The Israeli isolates have 85%-86% nt identity to cluster A and 75%-76% nt identity to cluster B.
In addition, full-length cDNA copies of individual EEV (from H3 and H8) genome segments were synthesized and amplifi ed by reverse transcription PCR by using the anchor spacer-ligation method as described (10, 11) . Partial sequences (for the upstream 450 bp) of Seg-2 from the different Israeli isolates were identical, showing 92.3% nt and 95.7% aa sequence identity with Seg-2 and VP2 of the Kaalplaas isolate, the reference isolate of EEV-3 (GenBank accession numbers are listed in Table 2 ). Previous phylogenetic comparisons of Seg-2/VP2 from different BTV types showed a maximum of 71% nt and 78% aa acid identity between serotypes (6), indicating that the isolates from Israel also belong to EEV type 3.
Conclusions
Equine encephalosis virus has long been enzootic to southern Africa, but it has not been isolated in other parts of the world. We report the characterization of an EEV strain isolated outside of Africa. Phylogenetic analysis of Seg-2 showed 92% sequence identity to EEV-3 (Kaalplaas).
Analysis of Seg-10 (the gene encoding NS3) of different orbiviruses showed 2 clusters of South African EEV strains (A and B), in agreement with previously published studies (9) . These 2 clusters appear to correlate with the geographic origins of the viruses in South Africa, independent of their isolation date. It has been suggested that the 2 EEV Seg-10 clusters in South Africa are related to the distribution of their Culicoides spp. midge vectors, C. imicola (senso stricto) and C. bolitinos. The former is the most abundant Culicoides spp. midge in Israel (12) . However, the EEV isolates from Israel group as a distinct cluster (C) with similar distances to the 2 South African clusters, raising questions concerning the geographic origin of this virus. A similar fi nding has been observed in African horse sickness virus Seg-10, which also forms into 3 distinct groups (13) . The question of how and when the virus was initially introduced to Israel remains unanswered. Because the clinical manifestations of equine encephalosis are usually mild, it is often overlooked and underdiagnosed. EEV could have been introduced to Israel before the virus was fi rst isolated in 2009. Alternatively, the virus might have been introduced into neighboring countries and transmitted into Israel by infected vectors carried by winds, as described for other orbiviruses (14, 15) . The fact that the Israeli strain of EEV-3 grouped in a different cluster than the 2 South African strains, supports the idea that it has evolved in this region for a suffi cient time to accumulate these changes and most likely was not recently introduced into Israel from South Africa. 
